Skip to main content
SpringerLink
Log in

Venetoclax/zanubrutinib

Non‑traumatic splenic rupture: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Qin Y, et al. Non-traumatic splenic rupture after discontinuation of zanubrutinib and venetoclax therapy in relapsed/refractory diffuse large B-cell lymphoma. Annals of Hematology 101: 2379-2380, No. 10, Oct 2022. Available from: URL: http://doi.org/10.1007/s00277-022-04925-5

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Venetoclax/zanubrutinib. Reactions Weekly 1927, 518 (2022). https://doi.org/10.1007/s40278-022-25254-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-25254-y

Search

Navigation